Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VPHM - Viropharma Inc -- Ignore unavailable to you. Want to Upgrade?

To: Cacaito who wrote (892)	3/15/2002 7:19:07 PM
From: Cacaito	Respond to of 2557

Tuesday #5: Approval and the shorts are realy mess up, and I am a buyer at $25 !!! Very small chances, but Why Would anyone trust Fulcrum? they are going to make their money since the $30s, the shorting is not new and the pressure Monday and Tuesday will drop the stock further. With Approval Fulcrum will gently and simply switch to the long side and squeeze the idiot retail investors who follow without a cut loss order, that will not save them much. The drug barely works, but so are Relenza and Tamiflu, and they were approved.